Current Report Filing (8-k)
November 19 2014 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 13, 2014
Date of report (Date of earliest event reported)
SOLAZYME,
INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| Delaware |
|
001-35189 |
|
33-1077078 |
| (State or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification Number) |
225 Gateway Boulevard
South San Francisco, CA 94080
(Address of Principal Executive Offices)
94080
(Zip Code)
(650) 780-4777
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former
name or former address, if changed since last report.)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b)
As disclosed on
October 9, 2014, Ann Mather, a director of Solazyme, Inc. (the “Company”) and Chair of the Company’s Audit Committee, informed the Company that she intended to transition her responsibilities as Audit Committee Chair and
thereafter intended to resign as Audit Committee Chair and a director of the Company prior to the end of 2014. Consistent with this, on November 13, 2014, Ms. Mather provided notice of her resignation as a director of the Company,
effective as of November 30, 2014.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
SOLAZYME, INC. |
|
|
|
|
(Registrant) |
|
|
|
|
| Date: November 19, 2014 |
|
|
|
By: |
|
/s/ PAUL T. QUINLAN |
|
|
|
|
|
|
Paul T. Quinlan |
|
|
|
|
|
|
General Counsel |